About Careers MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Economic Burden Of Dengue In Burkina Faso, Kenya, And Cambodia Studied

by Rishika Gupta on March 3, 2019 at 10:41 AM
Font : A-A+

 Economic Burden Of Dengue In Burkina Faso, Kenya, And Cambodia Studied

The average cost of inpatient care was found to be $26 in Burkina Faso and $134 in Cambodia, while the average cost of outpatient care was $13 per episode in Burkina Faso and $23 in Kenya. It was also found that the majority of the expenses were directly spent as out of pocket money by the patients.

Dengue fever is a major public health concern in many parts of South-East Asia and South America and its prevalence in Africa is thought to be expanding. Researchers have now analyzed the economic burden of dengue fever in Burkina Faso, Kenya, and Cambodia. Their results appear this week in PLOS Neglected Tropical Diseases.

Advertisement


Dengue fever is a vector-borne disease transmitted by Aedes mosquitos. While there are studies on the economic burden of dengue in some countries with high prevalence of the disease, countries in Africa had not previously been analyzed, and cost comparisons between countries are often not standardized.

In the new work, as part of the Dengue Vaccine Initiative (DVI) Jung-Seok Lee, and colleagues developed a patient-specific survey questionnaire on the cost of dengue and administered it to patients in six countries in a standardized manner. The survey included multiple interviews to capture both public and private (out-of-pocket costs). Data was previously published on the economic burden of dengue in Vietnam, Thailand, and Colombia; the new paper deals with the cost of the illness in Burkina Faso, Kenya and Cambodia.
Advertisement

Four hundred fourteen patients with dengue were identified at the field sites in Burkina Faso, 149 in Kenya, and 254 in Cambodia. The average cost of inpatient care was $26 in Burkina Faso and $134 in Cambodia, while the average cost of outpatient care was $13 per episode in Burkina Faso and $23 in Kenya. In both African countries, the majority of costs were directly borne by patients and the costs were not insignificant compared to the economic cost of malaria, a major pathogen in the areas.

"The economic burden outcomes presented in the current study can be used to estimate more accurate vaccination benefits when conducting a cost-effectiveness analysis of dengue fever vaccine interventions in the three countries in the future," the researchers say.

Source: Eurekalert
Advertisement

Advertisement
Advertisement

Recommended Reading

Latest Dengue News

Consult a Doctor Before Taking Medicines to Treat Dengue, Malaria or Chikungunya
Mosquito-borne diseases like dengue, malaria and chikungunya cases expected to ramp up after the recent rains. Consult a doctor before taking any medicine.
New Smartphone Clip-on can Detect Zika Virus in Blood Samples: Study
The clip-on detector is small and researchers are developing even smaller and similar devices to detect other mosquito-borne viruses.
National Dengue Day 2022: Symptoms and Prevention of Dengue
May 16 is our National Dengue Day, which is an initiative by Indian Government to spread awareness about the vector-borne disease and its preventive methods.
COVID-19 Restrictions Reduced Nearly 750,000 Dengue Cases in 2020
Globally, about three quarters of a million fewer global dengue cases have been occurred in 2020.
Gurugram Increases Screening at Border to Stop Dengue-Malaria Cases
Dengue and malaria cases have increased in the national capital and Gurugram has increased screening at the border to curb the rising cases.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
×

Economic Burden Of Dengue In Burkina Faso, Kenya, And Cambodia Studied Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests